FDA Approved: LEXISCAN — Supplemental Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approved a supplemental application for LEXISCAN (regadenoson), resulting in changes to the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• Lexiscan (regadenoson)

Snippet

SUPPL AP for LEXISCAN (REGADENOSON)